Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAG | P20916 | 5/20 | 0.56 |
| ▸ | SIGLEC7 | Q9Y286 | 2/20 | 0.53 |
| ▸ | SELL | P14151 | 1/20 | 0.50 |
| ▸ | SELP | P16109 | 1/20 | 0.50 |
| ▸ | CD22 | P20273 | 12/20 | 0.49 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL22259190 | 0.93 | MAG (0.55) | MAGSIGLEC7SELLSELPCD22 | |
| SCHEMBL25658072 | 0.91 | SIGLEC7 (0.57) | MAGSIGLEC7SELLSELPCD22 | |
| SCHEMBL29379331 | 0.91 | MAG (0.58) | MAGSIGLEC7SELLSELPCD22 | |
| SCHEMBL27420912 | 0.90 | SIGLEC7 (0.56) | MAGSIGLEC7SELLSELPCD22 | |
| SCHEMBL29540690 | 0.87 | MAG (0.64) | MAGSIGLEC7SELLSELP | |
| SCHEMBL23857822 | 0.86 | MAG (0.62) | MAGSIGLEC7SELLSELPCD22 | |
| SCHEMBL29361397 | 0.86 | MAG (0.62) | MAGSIGLEC7SELLSELPCD22 | |
| SCHEMBL25787350 | 0.85 | MAG (0.59) | MAGSIGLEC7SELLSELPCD22 | |
| SCHEMBL13415594 | 0.85 | MAG (0.59) | MAGSIGLEC7SELLSELPCD22 | |
| SCHEMBL21570085 | 0.85 | SIGLEC7 (0.62) | MAGSIGLEC7SELLSELP |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 40 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4742901-A1 | METHOD TO IMPROVE A PLANT'S GROWTH, DEVELOPMENT AND RESISTANCE TO (A)BIOTIC STRESS | Globachem NV (BE) | 2026-05-20 | — | — | EP | disclosed |
| EP-4743567-A1 | CELLULAR PRODUCTION OF LACTO-N-TRIOSE (LN3)-CONTAINING OLIGOSACCHARIDES | Inbiose N.V. (BE) | 2026-05-20 | — | — | EP | disclosed |
| EP-4742900-A1 | METHOD TO IMPROVE A PLANT'S GROWTH, DEVELOPMENT AND RESISTANCE TO (A)BIOTIC STRESS | Globachem NV (BE) | 2026-05-20 | — | — | EP | disclosed |
| EP-4742902-A1 | METHOD TO IMPROVE A PLANT'S GROWTH, DEVELOPMENT AND RESISTANCE TO (A)BIOTIC STRESS | Globachem NV (BE) | 2026-05-20 | — | — | EP | disclosed |
| EP-4742899-A1 | METHOD TO IMPROVE A PLANT'S GROWTH, DEVELOPMENT AND RESISTANCE TO (A)BIOTIC STRESS | Globachem NV (BE) | 2026-05-20 | — | — | EP | disclosed |
| US-12600997-B2 | Fermentative production of sialylated saccharides | CHR. HANSEN A/S (DK) | 2026-04-14 | — | — | US | disclosed |
| EP-4704597-A1 | METHOD TO REDUCE FEED CONVERSION RATIO IN A FARMED ANIMAL | Inbiose N.V. (BE) | 2026-03-11 | — | — | EP | disclosed |
| EP-4704599-A1 | FUCOSYLATED MAMMALIAN MILK OLIGOSACCHARIDE FOR USE IN THE PREVENTION OR TREATMENT OF SHIPPING FEVER | Inbiose N.V. (BE) | 2026-03-11 | — | — | EP | disclosed |
| EP-4704598-A1 | FUCOSYLATED MAMMALIAN MILK OLIGOSACCHARIDE FOR USE IN THE PREVENTION OR TREATMENT OF PNEUMONIA | Inbiose N.V. (BE) | 2026-03-11 | — | — | EP | disclosed |
| CN-121628994-A | Sialyl-N-acetyl lactosamine and synthesis thereof | 中科合生生物工程科技(珠海横琴)有限公司 | 2026-03-10 | — | — | CN | disclosed |
| US-20220347196-A1 | COMPOSITIONS AND METHODS FOR IMPROVING GASTROINTESTINAL FUNCTION IN SUBJECTS WITH RENAL DISEASE | KHARAIT SOURABH (US) | 2022-11-03 | — | — | US | disclosed |
| WO-2022232527-A1 | COMPOSITIONS AND METHODS FOR IMPROVING GASTROINTESTINAL FUNCTION IN SUBJECTS WITH RENAL OR LIVER DISEASES | IGH NATURALS, INC. (US) | 2022-11-03 | — | — | WO | disclosed |
| EP-3575404-B1 | FERMENTATIVE PRODUCTION OF SIALYLATED SACCHARIDES | CHR HANSEN HMO GMBH (DE) | 2022-10-19 | — | — | EP | disclosed |
| CN-115112799-A | Method for qualitatively detecting acid oligosaccharide in breast milk | 北京三元食品股份有限公司 | 2022-09-27 | — | — | CN | disclosed |
| US-20220145342-A1 | FERMENTATIVE PRODUCTION OF CARBOHYDRATES BY MICROBIAL CELLS UTILIZING A MIXED FEEDSTOCK | CHR. HANSEN A/S (DK) | 2022-05-12 | — | — | US | disclosed |
| US-20220110866-A1 | COMPOSITIONS AND METHODS FOR IMPROVING GASTROINTESTINAL ABSORPTION OF ELECTROLYTES | IGH NATURALS INC (US) | 2022-04-14 | — | — | US | disclosed |
| US-20220099666-A1 | MULTIVALENT GLYCAN MICROARRAY PLATFORM | Z BIOTECH, LLC (US) | 2022-03-31 | — | — | US | disclosed |
| US-11285105-B2 | Compositions and methods for improving gastrointestinal absorption of electrolytes | IGH NATURALS, INC. (US) | 2022-03-29 | — | — | US | disclosed |
| WO-2022026994-A1 | COMPOSITIONS AND METHODS FOR IMPROVING GASTROINTESTINAL ABSORPTION OF ELECTROLYTES | IGH NATURALS, INC. (US) | 2022-02-03 | — | — | WO | disclosed |
| US-20220031613-A1 | COMPOSITIONS AND METHODS FOR IMPROVING GASTROINTESTINAL ABSORPTION OF ELECTROLYTES | IGH NATURALS, INC. | 2022-02-03 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12600997-B2 | Fermentative production of sialylated saccharides | RNGTT, NANS, ENGASE | MAG 1383/4885SIGLEC7 250/4885SELL 1815/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.